Free Trial

Arrowstreet Capital Limited Partnership Decreases Stake in Select Medical Holdings Co. (NYSE:SEM)

Select Medical logo with Medical background
Remove Ads

Arrowstreet Capital Limited Partnership lowered its position in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 10.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 744,350 shares of the health services provider's stock after selling 83,150 shares during the quarter. Arrowstreet Capital Limited Partnership owned about 0.57% of Select Medical worth $14,031,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. LPL Financial LLC lifted its position in Select Medical by 2.0% in the fourth quarter. LPL Financial LLC now owns 31,441 shares of the health services provider's stock valued at $593,000 after buying an additional 619 shares during the last quarter. Quarry LP purchased a new position in shares of Select Medical during the 3rd quarter worth approximately $30,000. Sippican Capital Advisors increased its holdings in Select Medical by 7.3% in the 4th quarter. Sippican Capital Advisors now owns 13,354 shares of the health services provider's stock valued at $252,000 after purchasing an additional 912 shares during the last quarter. State of New Jersey Common Pension Fund D raised its position in Select Medical by 2.2% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 56,719 shares of the health services provider's stock valued at $1,069,000 after purchasing an additional 1,234 shares during the period. Finally, Smartleaf Asset Management LLC boosted its position in shares of Select Medical by 179.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after buying an additional 1,473 shares during the period. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Select Medical Stock Performance

NYSE:SEM traded up $1.25 during mid-day trading on Wednesday, reaching $17.00. 925,618 shares of the stock were exchanged, compared to its average volume of 809,184. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical Holdings Co. has a 1 year low of $14.99 and a 1 year high of $40.98. The company has a 50 day simple moving average of $17.71 and a 200-day simple moving average of $23.79. The stock has a market capitalization of $2.19 billion, a P/E ratio of 10.30, a P/E/G ratio of 0.64 and a beta of 1.38.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. Analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current fiscal year.

Select Medical Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd were issued a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend was Monday, March 3rd. Select Medical's payout ratio is currently 15.15%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on SEM. UBS Group decreased their target price on Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a research note on Friday, January 3rd. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective for the company in a research note on Monday, February 24th. StockNews.com upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a report on Friday, February 21st. Finally, Royal Bank of Canada dropped their price target on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a research note on Monday, February 24th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $27.25.

Get Our Latest Stock Analysis on Select Medical

About Select Medical

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Stories

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Congress Bought THESE Stocks as Tariffs Tanked the Market

Congress Bought THESE Stocks as Tariffs Tanked the Market

Reports of congressional buying and selling during the tariff meltdown are coming in; find out which companies members of Congress bought and sold.

Related Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
Donald Trump Owns These 7 Stocks, Should You?
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads